Metabolism Assays Market worth $2.1 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479 Browse in-depth TOC on "Metabolism Assays Market"126 - Tables38 - Figures 192 - Pages Metabolism Assays Market Scope: Assay Kits and reagents segment is expected to account for the larger share in 2022. The metabolism assay market, by product, has been segmented...

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479

Browse in-depth TOC on "Metabolism Assays Market"
126 - Tables
38 - Figures
192 - Pages

Metabolism Assays Market Scope:

Assay Kits and reagents segment is expected to account for the larger share in 2022.

The metabolism assay market, by product, has been segmented into instruments & analyzers and assay kits & reagents. In 2022, the assay kits & reagents dominated the products market and are also estimated to grow at the highest CAGR during the forecast period. The large share is due to the recurrence of assay kits & reagents and easy availability.

The diagnostic segment held the largest market share in the metabolism assay market.

By application, the global metabolism assay market is broadly segmented into diagnostics and research. The diagnostics segment accounted for the larger share of the market in 2022. The diagnostics segment is also estimated to grow at the highest CAGR during the forecast period. The large share of this segment can be attributed to various factors, such as the growing number of obese population and the growing number of hospitals which are important end users for metabolism assays.

North America dominates the global metabolism assay market.

Based on the region, the metabolism assay market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North American market is driven by well-established pharmaceutical and biotechnology industry, investments around drug discovery and toxicity testing. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. The presence of a large population base coupled with large patient population and increasing rate of obesity are some of the major factors driving the growth of this regional market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=135163479

Metabolism Assays Market Dynamics:

Drivers:

1.  Increasing funding and investments in metabolic research

Restraints:

1.  High cost of metabolism assay analyzers

Opportunities:

1.  Integration with wearable devices

Challenge:

1.  Complexity of assay development

Key Market Players:

Major players in metabolism assays market include Merck KGaA (Germany), Thermo Fisher (US), Abcam Plc. (UK), Agilent Technologies Inc. (US), and Kaneka Eurogentec S.A. (Belgium).

Recent Developments:

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=135163479

Metabolism Assays Market Advantages:

In summary, the metabolism assays market plays a pivotal role in advancing biomedical research and pharmaceutical development by offering a range of benefits, from accelerating drug discovery to enabling personalized medicine and improving the safety and efficacy of therapeutic interventions.

Related Reports:

CT/NG Testing Market - Global Forecasts to 2028

High Throughput Screening Market - Global Forecasts to 2028

ATP Assays Market - Global Forecasts to 2028

Cell-based Assays Market - Global Forecasts to 2028

Point of Care Molecular Diagnostics Market - Global Forecasts to 2028

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/metabolism-assays-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/metabolism-assays.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/metabolism-assays-market-worth-2-1-billion--marketsandmarkets-301941182.html